The Arrestin-selective Angiotensin AT1 Receptor Agonist [Sar1,Ile4,Ile8]-AngII Negatively Regulates Bradykinin B2 Receptor Signaling via AT1-B2 Receptor Heterodimers-Reference-Cited by-同舟云学术

The Arrestin-selective Angiotensin AT1 Receptor Agonist [Sar1,Ile4,Ile8]-AngII Negatively Regulates Bradykinin B2 Receptor Signaling via AT1-B2 Receptor Heterodimers

Published:2013-06 Issue:26 Volume:288 Page:18872-18884
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wilson Parker C.,Lee Mi-Hye,Appleton Kathryn M.,El-Shewy Hesham M.,Morinelli Thomas A.,Peterson Yuri K.,Luttrell Louis M.,Jaffa Ayad A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference60 articles.

1. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction;Schmaier;Am. J. Physiol. Regul. Integr. Comp. Physiol,2003

2. The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure;Oliveira;Physiol. Rev,2007

3. Angiotensin II cell signaling. Physiological and pathological effects in the cardiovascular system;Mehta;Am. J. Physiol. Cell Physiol,2007

4. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II;Hunyady;Mol. Endocrinol,2006

5. Drugs targeting the renin-angiotensin-aldosterone system;Zaman;Nat. Rev. Drug. Discov,2002

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer;Cellular and Molecular Life Sciences;2024-06-20

2. Evidence for heterodimerization and functional interaction of the urotensin II and the angiotensin II type 1 receptors;Cellular Signalling;2024-04

3. Unraveling the crosstalk between renin‐angiotensin system receptors;Acta Physiologica;2024-03-15

4. Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis;British Journal of Pharmacology;2023-01-17

5. Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor;Frontiers in Endocrinology;2022-05-26